Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study

Fig. 2

a SIBO-GSRS score between groups and their change over time. FMT, fecal microbiota transplantation; GSRS, Gastrointestinal Symptom Rating Scale. *month 1, 3 and 6 vs month 0 in FMT group (P < 0.05); # FMT group vs placebo group in different time-point (P < 0.05). b–f Average score of abdominal pain, reflux, indigestion, diarrhea and constipation in FMT and placebo group, significant difference was compared between FMT group vs placebo group in different time-point (*: P < 0.05; **: P < 0.01; ***: P < 0.001; ****: P < 0.0001)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us